Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$8.73B |
| 2 |
Royal Bank of Canada
RY
|
+$663M |
| 3 |
CRH
CRH
|
+$659M |
| 4 |
QXO
QXO Inc
QXO
|
+$637M |
| 5 |
Broadcom
AVGO
|
+$506M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rocket Lab Corp
RKLB
|
+$801M |
| 2 |
Coupang
CPNG
|
+$756M |
| 3 |
Meta Platforms (Facebook)
META
|
+$549M |
| 4 |
Atlassian
TEAM
|
+$516M |
| 5 |
Netflix
NFLX
|
+$496M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.53% |
| 2 | Technology | 23.52% |
| 3 | Industrials | 15.72% |
| 4 | Communication Services | 13.46% |
| 5 | Healthcare | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ginkgo Bioworks
DNA
$468M
| $23.7M | 0.02% |
2,391,649
| – | – |
|
177
Impinj
PI
$5.35B
| $22.3M | 0.02% |
155,965
-18,150
| -10% | -$2.37M |
|
178
Universal Technical Institute
UTI
$1.19B
| $21.7M | 0.02% |
507,700
-59,161
| -10% | -$2.27M |
|
179
Kornit Digital
KRNT
$690M
| $21.2M | 0.02% |
1,302,546
-199,227
| -13% | -$3.15M |
|
180
Procept Biorobotics
PRCT
$1.22B
| $20.6M | 0.02% |
911,751
-61,751
| -6% | -$1.55M |
|
181
MP Materials
MP
$9.58B
| $20M | 0.02% |
357,468
-96,403
| -21% | -$5.87M |
|
182
Aehr Test Systems
AEHR
$2.49B
| $19.6M | 0.02% |
203,878
-797,140
| -80% | -$72.8M |
|
183
Infosys
INFY
$49B
| $19.3M | 0.02% |
1,843,512
-4,908
| -0.3% | -$61.5K |
|
184
IPG Photonics
IPGP
$3.25B
| $18.8M | 0.02% |
160,499
-108,856
| -40% | -$12.5M |
|
185
Kratos Defense & Security Solutions
KTOS
$9.03B
| $18.1M | 0.02% |
362,296
+94,733
| +35% | +$5.73M |
|
186
Transmedics
TMDX
$3.02B
| $17.8M | 0.02% |
267,935
-37,259
| -12% | -$3.15M |
|
187
Stoke Therapeutics
STOK
$1.94B
| $16.9M | 0.02% |
517,275
-57,907
| -10% | -$1.86M |
|
188
Appian
APPN
$2.92B
| $16.8M | 0.02% |
735,158
-170,750
| -19% | -$3.8M |
|
189
NovoCure
NVCR
$2.05B
| $14.4M | 0.01% |
952,074
-119,510
| -11% | -$1.81M |
|
190
Berkshire Hathaway Class B
BRK.B
$1.09T
| $14.4M | 0.01% |
+28,779
| New | +$13.8M |
|
|
CHYM
191
Chime Financial
CHYM
$12.7B
| $13.9M | 0.01% |
678,717
| – | – |
|
192
Amplitude
AMPL
$1.69B
| $13.6M | 0.01% |
1,779,555
-854,595
| -32% | -$5.89M |
|
193
Doximity
DOCS
$4.83B
| $13.3M | 0.01% |
643,675
-3,195,952
| -83% | -$70.7M |
|
|
MRLN
194
Merlin Inc
MRLN
$340M
| $11.5M | 0.01% |
2,016,289
| – | – |
|
195
Monster Beverage
MNST
$86.4B
| $11.2M | 0.01% |
233,476
-173,936
| -43% | -$7.31M |
|
196
Banco de Chile
BCH
$21.7B
| $10.9M | 0.01% |
274,045
+45
| +0% | +$1.71K |
|
197
Beam Therapeutics
BEAM
$3.04B
| $10.8M | 0.01% |
314,228
-71,663
| -19% | -$2.16M |
|
198
Intel
INTC
$485B
| $10.5M | 0.01% |
75,295
+74,826
| +15,954% | +$7.57M |
|
199
WEC Energy
WEC
$34.8B
| $10.3M | 0.01% |
87,935
-7,307
| -8% | -$834K |
|
200
CenterPoint Energy
CNP
$26.3B
| $10.2M | 0.01% |
230,995
-97,938
| -30% | -$4.2M |
|
Similar funds
Baillie Gifford & Co's Q2 2026 Portfolio in Review
As of Q2 2026, Baillie Gifford & Co held 299 positions worth $110B, up 13% from $97.9B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Baillie Gifford & Co deployed $4.53B of net new capital in Q2 2026, opening 28 new positions and adding to 57 existing holdings. Its largest new stake was SpaceX: 51,397,806 shares worth $8.78B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Rocket Lab Corp, an estimated $801M trimmed.
- Baillie Gifford & Co's largest Q2 2026 buy was SpaceX: 51,397,806 shares worth $8.78B.
- Baillie Gifford & Co added most to Royal Bank of Canada in Q2 2026, an estimated $663M increase.
- Baillie Gifford & Co's biggest Q2 2026 reduction was Rocket Lab Corp, cutting an estimated $801M.
- Baillie Gifford & Co fully exited Penumbra in Q2 2026, selling an estimated $276M.
- Baillie Gifford & Co's ten largest holdings make up 45% of its $110B portfolio in Q2 2026.
- Baillie Gifford & Co opened 28 new positions and closed 26 in Q2 2026.
- Baillie Gifford & Co's portfolio value rose 13% quarter-over-quarter to $110B.
Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.